{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:51:44Z","timestamp":1790009504095,"version":"4.0.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.ijantimicag.2012.04.010","type":"journal-article","created":{"date-parts":[[2012,6,22]],"date-time":"2012-06-22T23:35:03Z","timestamp":1340408103000},"page":"140-144","source":"Crossref","is-referenced-by-count":36,"title":["Old agent, new experience: colistin use in the paediatric Intensive Care Unit\u2014a multicentre study"],"prefix":"10.1016","volume":"40","author":[{"given":"Muhammet Sukru","family":"Paksu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sule","family":"Paksu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adil","family":"Karadag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fclnar","family":"Sensoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazik","family":"Asilioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dincer","family":"Yildizdas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basak Nur","family":"Akyildiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanil","family":"Kendirli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demet","family":"Demirkol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammet","family":"Akgun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emine","family":"Alp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ergin","family":"Ciftci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akif Koray","family":"Guney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naci","family":"Murat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2012.04.010_bib0005","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1086\/528867","article-title":"Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among Gram-negative bacilli: need for international harmonization in terminology","volume":"46","author":"Falagas","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2012.04.010_bib0010","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/BCR.0B013E318053D346","article-title":"Intravenous colistin for the treatment of multi-drug resistant, Gram-negative infection in the pediatric burn population","volume":"28","author":"Goverman","year":"2007","journal-title":"J Burn Care Res"},{"key":"10.1016\/j.ijantimicag.2012.04.010_bib0015","doi-asserted-by":"crossref","DOI":"10.2807\/ese.13.47.19045-en","article-title":"Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe","volume":"13","author":"Souli","year":"2008","journal-title":"Euro Surveill"},{"key":"10.1016\/j.ijantimicag.2012.04.010_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/595011","article-title":"Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America","volume":"48","author":"Boucher","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2012.04.010_bib0025","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1442-200X.2009.03015.x","article-title":"Colistimethate sodium therapy for multidrug-resistant isolates in pediatric patients","volume":"52","author":"Celebi","year":"2010","journal-title":"Pediatr Int"},{"key":"10.1016\/j.ijantimicag.2012.04.010_bib0030","doi-asserted-by":"crossref","first-page":"503.e1","DOI":"10.1016\/j.ijantimicag.2008.10.021","article-title":"Systemic colistin use in children without cystic fibrosis: a systematic review of the literature","volume":"33","author":"Falagas","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2012.04.010_bib0035","doi-asserted-by":"crossref","first-page":"153","DOI":"10.4103\/0972-5229.45074","article-title":"Safety and efficacy of polymyxin B in multidrug resistant Gram-negative severe sepsis and septic shock","volume":"12","author":"Ramasubban","year":"2008","journal-title":"Indian J Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2012.04.010_bib0040","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ijantimicag.2009.11.016","article-title":"Safety and efficacy of intravenous colistin (colistin methanesulphonate) for severe multidrug-resistant Gram-negative bacterial infections","volume":"35","author":"Cheng","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2012.04.010_bib0045","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.2169\/internalmedicine.50.4270","article-title":"Efficacy and safety of colistin in the treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in patients with hematologic malignancy: a matched pair analysis","volume":"50","author":"Durakovic","year":"2011","journal-title":"Intern Med"},{"key":"10.1016\/j.ijantimicag.2012.04.010_bib0050","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00431-009-1137-3","article-title":"Colistin administration to pediatric and neonatal patients","volume":"169","author":"Iosifidis","year":"2010","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.ijantimicag.2012.04.010_bib0055","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0196-6553(88)90053-3","article-title":"CDC definitions for nosocomial infections, 1988","volume":"16","author":"Garner","year":"1988","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.ijantimicag.2012.04.010_bib0060","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/01.PCC.0000149131.72248.E6","article-title":"International Pediatric Sepsis Consensus Conference: definitions for sepsis and organ dysfunction in pediatrics","volume":"6","author":"Goldstein","year":"2005","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2012.04.010_bib0065","series-title":"Performance standards for antimicrobial susceptibility testing; twenty-first informational supplement. Document M100-S21","author":"Clinical and Laboratory Standards Institute","year":"2011"},{"key":"10.1016\/j.ijantimicag.2012.04.010_bib0070","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1086\/429323","article-title":"Colistin: the revival of polymyxins for the management of multidrug-resistant Gram-negative bacterial infections","volume":"40","author":"Falagas","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2012.04.010_bib0075","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/INF.0b013e3182064bfe","article-title":"Intravenous colistin administration in neonates","volume":"30","author":"Jajoo","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ijantimicag.2012.04.010_bib0080","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/BCR.0b013e3181abffb6","article-title":"Use of colistin in a pediatric burn unit in Argentina","volume":"30","author":"Rosanova","year":"2009","journal-title":"J Burn Care Res"},{"key":"10.1016\/j.ijantimicag.2012.04.010_bib0085","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/INF.0b013e31818a5dbd","article-title":"Intravenous colistimethate (colistin) use in critically ill children without cystic fibrosis","volume":"28","author":"Falagas","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ijantimicag.2012.04.010_bib0090","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1086\/514732","article-title":"Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii","volume":"28","author":"Levin","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2012.04.010_bib0095","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1086\/374337","article-title":"Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP","volume":"36","author":"Garnacho-Montero","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2012.04.010_bib0100","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4103\/0972-5229.56048","article-title":"Colistin and polymyxin B: a re-emergence","volume":"13","author":"Gupta","year":"2009","journal-title":"Indian J Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2012.04.010_bib0105","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1128\/CMR.00006-08","article-title":"Polymyxins revisited","volume":"21","author":"Landman","year":"2008","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2012.04.010_bib0110","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/j.1469-0691.2008.02061.x","article-title":"Colistin monotherapy vs. combination therapy: evidence from microbiological, animal and clinical studies","volume":"14","author":"Petrosillo","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2012.04.010_bib0115","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1378\/chest.72.6.794","article-title":"Endocarditis due to Pseudomonas aeruginosa in a heroin addict. Successful treatment with trimethoprim\u2013sulfamethoxazole mixture plus colistin","volume":"72","author":"Yoshikawa","year":"1977","journal-title":"Chest"},{"key":"10.1016\/j.ijantimicag.2012.04.010_bib0120","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ijantimicag.2005.10.012","article-title":"In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units","volume":"27","author":"Timurkaynak","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2012.04.010_bib0125","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/j.1469-0691.2006.01559.x","article-title":"Effectiveness and nephrotoxicity of colistin monotherapy vs. colistin\u2013meropenem combination therapy for multidrug-resistant Gram-negative bacterial infections","volume":"12","author":"Falagas","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2012.04.010_bib0130","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.1086\/379611","article-title":"Use of parenteral colistin for the treatment of serious infection due to antimicrobial-resistant Pseudomonas aeruginosa","volume":"37","author":"Linden","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2012.04.010_bib0135","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1128\/AAC.01799-09","article-title":"Serum and cerebrospinal fluid levels of colistin in pediatric patients","volume":"54","author":"Antachopoulos","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2012.04.010_bib0140","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s10096-001-0680-2","article-title":"Cerebrospinal fluid penetration and pharmacokinetic\/pharmacodynamic parameters of intravenously administered colistin in a case of multidrug-resistant Acinetobacter baumannii meningitis","volume":"21","author":"Jim\u00e9nez-Mej\u00edas","year":"2002","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2012.04.010_bib0145","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/INF.0b013e3181ac4980","article-title":"Use of colistin in children","volume":"28","author":"Tamma","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ijantimicag.2012.04.010_bib0150","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-72-6-857","article-title":"Adverse effects of sodium colistimethate. Manifestations and specific reaction rates during 317 courses of therapy","volume":"72","author":"Koch-Weser","year":"1970","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijantimicag.2012.04.010_bib0155","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ijantimicag.2005.09.004","article-title":"Nephrotoxicity of intravenous colistin: a prospective evaluation","volume":"26","author":"Falagas","year":"2005","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2012.04.010_bib0160","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1177\/00912700122010537","article-title":"The pharmacokinetics of colistin in patients with cystic fibrosis","volume":"41","author":"Reed","year":"2001","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.ijantimicag.2012.04.010_bib0165","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S1473-3099(06)70580-1","article-title":"Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections","volume":"6","author":"Li","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2012.04.010_bib0170","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jinf.2008.01.003","article-title":"Intravenous colistin sulphomethate sodium for therapy of infections due to multidrug-resistant Gram-negative bacteria","volume":"56","author":"Pintado","year":"2008","journal-title":"J Infect"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092485791200180X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092485791200180X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T10:41:00Z","timestamp":1642588860000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092485791200180X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S092485791200180X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2012.04.010","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}